Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis

@inproceedings{Barbieri2016Wip1IG,
  title={Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis},
  author={Elena Barbieri and Long Mei Wang and Dayong Yao and Tianshu Yang and Wen-ming Cao and Jun Dou and Jonathan C. Pang and S Guan and Huiyuan Zhang and Yang Yu and Yanling Zhao and Yongfeng Wang and Xin Xu and Yan Shi and Roma H. Patel and Hong Zhang and Sanjeev A. Vasudevan and Shangfeng Liu and Jianhua Yang and Jed G. Nuchtern},
  booktitle={Scientific reports},
  year={2016}
}
Neuroblastoma (NB) is the most common extracranial tumor in children. Unlike in most adult tumors, tumor suppressor protein 53 (p53) mutations occur with a relatively low frequency in NB and the downstream function of p53 is intact in NB cell lines. Wip1 is a negative regulator of p53 and hindrance of Wip1 activity by novel inhibitor GSK2830371 is a potential strategy to activate p53's tumor suppressing function in NB. Yet, the in vivo efficacy and the possible mechanisms of GSK2830371 in NB… CONTINUE READING
BETA
1
Twitter Mention

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-9 OF 9 CITATIONS

WIP1 phosphatase as pharmacological target in cancer therapy

  • Journal of Molecular Medicine
  • 2017
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Small molecule activators of the p53 response

  • Journal of molecular cell biology
  • 2019
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 57 REFERENCES